IRIDEX (IRIX)
(Delayed Data from NSDQ)
$1.89 USD
-0.05 (-2.58%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.87 -0.02 (-1.06%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.89 USD
-0.05 (-2.58%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.87 -0.02 (-1.06%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth A Momentum B VGM
Zacks News
Rockwell Medical Stock Surges 108.5% YTD: Should You Snap it Up Now?
by Urmimala Biswas
RMTI continues to outperform its peers, banking on its focus on optimizing business to drive sustainable profitability and meaningful cash flow generation.
Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Iridex (IRIX) delivered earnings and revenue surprises of -33.33% and 1.32%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Iridex (IRIX) delivered earnings and revenue surprises of -75% and 1.99%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Lumentum (LITE) Q3 Earnings Beat Estimates
by Zacks Equity Research
Lumentum (LITE) delivered earnings and revenue surprises of 11.54% and 0.01%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Iridex (IRIX) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
IRIDEX (IRIX) delivered earnings and revenue surprises of -260% and 16.39%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights MicroVision, Cutera and IRIDEX
by Zacks Equity Research
MicroVision, Cutera and IRIDEX have been highlighted in this Industry Outlook article.
3 Laser Systems Stocks to Watch in a Challenging Industry
by Aniruddha Ganguly
The Zacks Laser Systems and Components industry participants like MicroVision (MVIS), Cutera (CUTR) and IRIDEX Corporation (IRIX) gain from solid demand for emerging applications like autonomous driving, IoT, 5G and healthcare amid challenging macroeconomic conditions.
IPG Photonics (IPGP) Q4 Earnings Miss Estimates
by Zacks Equity Research
IPG (IPGP) delivered earnings and revenue surprises of -6.32% and 4.58%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
IPG Photonics (IPGP) Q3 Earnings Surpass Estimates
by Zacks Equity Research
IPG (IPGP) delivered earnings and revenue surprises of 14.85% and 3.68%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Iridex (IRIX) delivered earnings and revenue surprises of -54.55% and 9.66%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights IPG Photonics and IRIDEX
by Zacks Equity Research
IPG Photonics and IRIDEX have been highlighted in this Industry Outlook article.
2 Laser Systems Stocks to Buy in a Prospering Industry
by Aniruddha Ganguly
The Zacks Laser Systems and Components industry participants like IPG Photonics (IPGP) and IRIDEX (IRIX) gain from solid demand for emerging applications like autonomous driving, IoT, 5G and healthcare.
Iridex (IRIX) Is Attractively Priced Despite Fast-paced Momentum
by Zacks Equity Research
Iridex (IRIX) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Iridex (IRIX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Iridex (IRIX) delivered earnings and revenue surprises of -8.33% and 0.48%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Lumentum (LITE) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Lumentum (LITE) delivered earnings and revenue surprises of -9.64% and 2.46%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Iridex (IRIX) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Iridex (IRIX) delivered earnings and revenue surprises of 36.36% and 0.20%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Agilent Technologies (A) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 4.58% and 3.78%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
IPG Photonics (IPGP) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
IPG (IPGP) delivered earnings and revenue surprises of -309.89% and 5.72%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Iridex (IRIX) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Iridex (IRIX) delivered earnings and revenue surprises of 26.67% and 5.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Lumentum (LITE) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Lumentum (LITE) delivered earnings and revenue surprises of 8.33% and 0.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cutera (CUTR) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Cutera (CUTR) delivered earnings and revenue surprises of 20% and 0.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Iridex (IRIX) delivered earnings and revenue surprises of 12.50% and 1.22%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Glaukos (GKOS) Strong Portfolio Driving Sales Amid Competition
by Zacks Equity Research
Glaukos (GKOS) continues to benefit from a robust product portfolio and a strong pipeline. However, stiff competition remains a woe.
IPG Photonics (IPGP) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
IPG (IPGP) delivered earnings and revenue surprises of 23.21% and 3.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Iridex (IRIX) delivered earnings and revenue surprises of 6.25% and 0.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?